Prison needle programs get a boost to fight HIV and hepatitis c

NCT ID NCT07122219

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how to get more people in Canadian federal prisons to use needle exchange programs, which can help stop the spread of HIV and hepatitis C. Researchers will work in nine prisons, including five women's prisons, to find out what helps or hinders program use and put better strategies in place. About 548 incarcerated individuals will take part, with the goal of making these life-saving programs more effective and sustainable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATITIS C VIRUS (HCV) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Atlantic Institution

    RECRUITING

    Smiths Crossing, New Brunswick, E9B 1T9, Canada

  • Dorchester Medium

    RECRUITING

    Dorchester, New Brunswick, E4K 2Y9, Canada

  • Edmonton Institution for Women

    NOT_YET_RECRUITING

    Edmonton, Alberta, T5S 2H9, Canada

  • Fraser Valley Institution for Women

    NOT_YET_RECRUITING

    Abbotsford British Columbia, British Columbia, V2S 1A1, Canada

  • Grand Valley Institution for Women

    NOT_YET_RECRUITING

    Kitchener, Ontario, N2P 2C5, Canada

  • Joliette Institution for Women

    NOT_YET_RECRUITING

    Joliette, Quebec, J6E 8W1, Canada

  • Joyceville Institution

    NOT_YET_RECRUITING

    Kingston, Ontario, K7L 4X9, Canada

  • Mission Institution

    NOT_YET_RECRUITING

    Mission, British Columbia, V2V 4L8, Canada

  • Nova Institution for Women

    RECRUITING

    Truro, Nova Scotia, B2N 6R8, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.